Dahiya, S., Ulrickson, M., Yared, J., Reagan, P., Voorhees, T., Reshef, R., Turtle, C., Bachier-Rodriguez, L., Kersten, M. J., Topp, P. D. M. S., Simmons, G., Sanderson, R., Nastoupil, L., Jung, S., Granados, E., Dong, J., Winters, J., Shen, R., Kanska, J., Nahas, M., Ahmed, S. (2025). A Phase 1 study of KITE-753 or KITE-363 in patients with relapsed/refractory B-cell lymphoma: Initial safety and preliminary efficacy of KITE-753 and updated results of KITE-363. Blood. https://doi.org/10.1182/blood-2025-265